HUTCHMED (China) (HCM) Gross Margin (2015 - 2021)
HUTCHMED (China)'s (HCM) quarterly Gross Margin came in at 34.26% in Q2 2021, down 14441.0% year-on-year from N/an in Q2 2020, and down 136.85% on a QoQ basis from 92.97% in Q1 2021.
HUTCHMED (China) (HCM) Gross Margin (2015 - 2021) Analysis & Trends
HUTCHMED (China) (HCM) has 6 years of Gross Margin data on file, last reported at 34.26% in Q2 2021.
- On a quarterly basis, Gross Margin fell 14441.0% year-over-year to 34.26% in Q2 2021; TTM through Jun 2021 was 79.72%, a 5070.0% increase from a year earlier, with the FY2025 full-year figure at 6.93%, down 205.0% from the prior year.
- Gross Margin for Q2 2021 stood at 34.26%, down from 92.97% in the prior quarter.
- Over the last five years, Gross Margin for HCM reached as high as 226.43% in Q3 2019 and fell as low as 40.45% in Q2 2019.
- Historically, Gross Margin has averaged 85.85% across 4 years, with a median of 92.75% in 2018.
- Across the five-year window, Gross Margin soared 15059 bps in 2020 and slumped 14441 bps in 2021, its largest moves.
- Year by year, Gross Margin stood at 92.32% in 2018, then soared by 31 bps to 120.96% in 2019, then declined by 9 bps to 110.14% in 2020, then plunged by 131 bps to 34.26% in 2021.
- Per Business Quant data, the three most recent Gross Margin figures were 34.26% in Q2 2021, 92.97% in Q1 2021, and 110.14% in Q2 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 49.52% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 71.66% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 62.93% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 82.93% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 32.97% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 98.31% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 57.26% |
| 10 | HUTCHMED (China) | 241.90 Mn | 243.61 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | -34.26% |
| Mar 31, 2021 | 92.97% |
| Jun 30, 2020 | 110.14% |
| Mar 31, 2020 | 94.97% |
| Dec 31, 2019 | 120.96% |
| Sep 30, 2019 | 226.43% |
| Jun 30, 2019 | -40.45% |
| Mar 31, 2019 | 92.74% |
| Dec 31, 2018 | 92.32% |
| Sep 30, 2018 | 92.75% |
| Jun 30, 2018 | 90.42% |
| Mar 31, 2018 | 91.18% |
| Jun 30, 2016 | 71.54% |
| Jun 30, 2015 | 59.24% |